Cargando…
Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896600/ https://www.ncbi.nlm.nih.gov/pubmed/33602697 http://dx.doi.org/10.1136/jitc-2020-002252 |
| _version_ | 1783653572506812416 |
|---|---|
| author | Gatti-Mays, Margaret Gulley, James L |
| author_facet | Gatti-Mays, Margaret Gulley, James L |
| author_sort | Gatti-Mays, Margaret |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7896600 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78966002021-03-05 Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis Gatti-Mays, Margaret Gulley, James L J Immunother Cancer Editorial BMJ Publishing Group 2021-02-18 /pmc/articles/PMC7896600/ /pubmed/33602697 http://dx.doi.org/10.1136/jitc-2020-002252 Text en https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Editorial Gatti-Mays, Margaret Gulley, James L Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis |
| title | Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis |
| title_full | Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis |
| title_fullStr | Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis |
| title_full_unstemmed | Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis |
| title_short | Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis |
| title_sort | real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896600/ https://www.ncbi.nlm.nih.gov/pubmed/33602697 http://dx.doi.org/10.1136/jitc-2020-002252 |
| work_keys_str_mv | AT gattimaysmargaret realworldinsightsonpreferredtreatmentsforsteroidrefractoryimmunecheckpointinhibitorinducedpneumonitis AT gulleyjamesl realworldinsightsonpreferredtreatmentsforsteroidrefractoryimmunecheckpointinhibitorinducedpneumonitis |